T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity-Reference-Cited by-同舟云学术

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity

Published:2017-11-23 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Schmid Daniela,Park Chun Gwon,Hartl Christina A.,Subedi Nikita,Cartwright Adam N.^ORCID,Puerto Regina Bou,Zheng Yiran,Maiarana James,Freeman Gordon J.,Wucherpfennig Kai W.,Irvine Darrell J.,Goldberg Michael S.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-01830-8.pdf

Reference46 articles.

1. Lipson, E. J. et al. Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin. Cancer Res. 19, 462–468 (2013).

2. Friedman, C. F., Proverbs-Singh, T. A. & Postow, M. A. Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review. JAMA Oncol. 2, 1346–1353 (2016).

3. Naidoo, J. et al. Pneumonitis in patients treated with anti-Programmed Death-1/Programmed Death Ligand 1 therapy. J. Clin. Oncol. 35, 709–717 (2017).

4. Pickup, M., Novitskiy, S. & Moses, H. L. The roles of TGFβ in the tumour microenvironment. Nat. Rev. Cancer 13, 788–799 (2013).

5. Yingling, J. M., Blanchard, K. L. & Sawyer, J. S. Development of TGF-beta signalling inhibitors for cancer therapy. Nat. Rev. Drug Discov. 3, 1011–1022 (2004).

Cited by 366 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09

2. Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects;Frontiers in Immunology;2024-08-23

3. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

4. Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-08

5. Engineering Functional Particles to Modulate T Cell Responses;Accounts of Materials Research;2024-07-18